Exclusive

Publication

Byline

Location

US Patent Issued to Vertero Therapeutics on Oct. 27 for "Inhibitors of microbially induced amyloid" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,290, issued on Oct. 27, was assigned to Vertero Therapeutics Inc. (Woburn, Mass.). "Inhibitors of microbially induced amyloid" was invented... Read More


US Patent Issued to Grey Wolf Therapeutics on Oct. 27 for "Compounds as modulators of endoplasmic reticulum aminopeptidase 1 (ERAP1)" (British Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,291, issued on Oct. 27, was assigned to Grey Wolf Therapeutics Ltd. (Abingdon, Great Britain). "Compounds as modulators of endoplasmic reti... Read More


US Patent Issued to BP InnoMed on Oct. 27 for "LMP1 targeting lanthanide complexes and methods of use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,292, issued on Oct. 27, was assigned to BP InnoMed Ltd. (Hong Kong). "LMP1 targeting lanthanide complexes and methods of use thereof" was i... Read More


US Patent Issued to IDEMITSU KOSAN on Oct. 27 for "Compound, material for organic electroluminescent element, organic electroluminescent element and electronic device" (Swiss Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,293, issued on Oct. 27, was assigned to IDEMITSU KOSAN Co. LTD. (Tokyo). "Compound, material for organic electroluminescent element, organi... Read More


US Patent Issued to Advanced Material Solutions on Oct. 27 for "Method and system for selective recovery of monochlorosilane and dichlorosilane in polysilicon production process" (Montana Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,294, issued on Oct. 27, was assigned to Advanced Material Solutions LLC. "Method and system for selective recovery of monochlorosilane and ... Read More


US Patent Issued to TSINGHUA UNIVERSITY, BEIJING SYNTHETIC VACCINE BIOSCIENCES on Oct. 27 for "Substituted pyridin-2-amines as TLR8 agonists" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,296, issued on Oct. 27, was assigned to TSINGHUA UNIVERSITY (Beijing) and BEIJING SYNTHETIC VACCINE BIOSCIENCES Co. LTD (Beijing). "Substit... Read More


US Patent Issued to UNIVERSAL DISPLAY COROPRATION on Oct. 27 for "Organic electroluminescent materials and devices" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,297, issued on Oct. 27, was assigned to UNIVERSAL DISPLAY COROPRATION (Ewing, N.J.). "Organic electroluminescent materials and devices" was... Read More


US Patent Issued to GALECTO BIOTECH on Oct. 27 for "Amorphous form of 5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl-1-thio-alpha-d-galactopyranoside" (Danish, British Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,298, issued on Oct. 27, was assigned to GALECTO BIOTECH AB (Copenhagen, Denmark). "Amorphous form of 5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,... Read More


US Patent Issued to BIOVIE on Oct. 27 for "Crystalline solvate forms of a pharmaceutical" (Indiana, California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,300, issued on Oct. 27, was assigned to BIOVIE INC. (Carson City, Nev.). "Crystalline solvate forms of a pharmaceutical" was invented by St... Read More


US Patent Issued to The Coca-Cola on Oct. 27 for "Mogrosides, compositions and their purification" (Georgia, Arizona Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,301, issued on Oct. 27, was assigned to The Coca-Cola Co. (Atlanta). "Mogrosides, compositions and their purification" was invented by Indr... Read More